China NMPA Product Recall - Pulmona Testing System

Vyaire Medical GmbH, the manufacturer of the Pulmona Testing System, has initiated a voluntary Class II recall for the device due to a critical safety concern. This recall event was reported by Vyaire Medical Devices (Shanghai) Co., Ltd. and publicly announced by the National Medical Products Administration (NMPA) on July 4, 2024. The main issue identified is the potential detachment of the device's nozzle during operation. Such an occurrence could compromise the accuracy or effectiveness of the Pulmona Testing System, potentially leading to inaccurate test results or an interruption in critical diagnostic procedures. This type of defect necessitates a swift response to protect patient well-being and maintain confidence in medical device integrity. The regulatory framework underpinning this action involves adherence to medical device registration requirements, as indicated by the product's National Medical Device Registration Certificate No. 20242070183. A Class II recall signifies that the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. It is important to note that while Vyaire Medical GmbH is conducting this global recall, the specific products identified were not imported into the Chinese market, limiting the direct impact within China. The required action for the company is to manage this recall effectively, identifying and correcting the issue to prevent recurrence, and providing detailed information on affected models and batches through official channels.